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Abstract
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common healthcare-associated
pathogens. To examine the role of inter-hospital patient sharing on MRSA transmission, a previous study collected
2,214 samples from 30 hospitals in Orange County, California and showed by spa typing that genetic differentiation
decreased significantly with increased patient sharing. In the current study, we focused on the 986 samples with
spa type t008 from the same population.
Methods: We used genome sequencing to determine the effect of patient sharing on genetic differentiation
between hospitals. Genetic differentiation was measured by between-hospital genetic diversity, FST, and the
proportion of nearly identical isolates between hospitals.
Results: Surprisingly, we found very similar genetic diversity within and between hospitals, and no significant
association between patient sharing and genetic differentiation measured by FST. However, in contrast to FST,
there was a significant association between patient sharing and the proportion of nearly identical isolates between
hospitals. We propose that the proportion of nearly identical isolates is more powerful at determining transmission
dynamics than traditional estimators of genetic differentiation (FST) when gene flow between populations is high,
since it is more responsive to recent transmission events. Our hypothesis was supported by the results from
coalescent simulations.
Conclusions: Our results suggested that there was a high level of gene flow between hospitals facilitated by
patient sharing, and that the proportion of nearly identical isolates is more sensitive to population structure than
FST when gene flow is high.
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Background
Methicillin-resistant Staphylococcus aureus (MRSA) is a
leading cause of hospital-associated infections [1–4], with
around 75,000 invasive MRSA infections reported in the
United States in 2012 [5]. MRSA colonizes sites including
the axilla, groin, gastrointestinal tract, and nares, and is
typically spread via skin-to-skin contact, or contaminated
medical devices [6, 7]. In hospitalized patients, MRSA
causes a wide breadth of infections, including skin and soft-
tissue infections, pneumonia, endocarditis, septic arthritis,
osteomyelitis, device-associated infections, bacteremia, and
sepsis [8]. Risk factors for MRSA infections include previ-
ous hospitalization, wounds, invasive medical devices, and
immune system impairment [9, 10].
Understanding transmission dynamics within and be-
tween hospitals, between community and hospital, and
within the community is important for disease control.
Transmission-dynamic modeling has suggested that an
MRSA outbreak in one facility contributes to MRSA
prevalence in other connected healthcare facilities
[11–14]. Different scales of genetic data have been used
to study within- and/or between- hospital transmission.
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Ke et al. collected samples from 30 hospitals in Orange
County, California and showed by spa typing that genetic
differentiation decreases significantly with patient transfer
between hospitals [15]. Using genome sequencing data,
Long et al. found no evidence of within-hospital transmis-
sion between patients with sterile-site infections in four
hospitals in Houston [16] and Prosperi et al. reported no
phylogeographic clustering of samples from the same hos-
pitals in northeast Florida [17].
The spa typing method involves the sequencing of a
polymorphic variable-number tandem repeat within the
3′ coding region of the protein A-encoding gene (spa)
and is one of the standard tools for MRSA surveillance
studies [18–21]. Protein A binds immunoglobulins, and
due to its important function in host-parasite inter-
action, demographic effects inferred from spa typing can
possibly be biased by natural selection. More import-
antly, it has been suggested that the limited variation in
spa typing hampers its power to detect spatial spread
over local scales [22–24]. Although Ke et al. [15] suc-
cessfully identified the effect of patient sharing in a local
setting (Orange County, California) using spa typing,
with most samples having the same spa type t008, the
signal relied on the unusual spa types and might not
reflect the overall transmission dynamics. Here, we fo-
cused on spa type t008/USA300, the dominant commu-
nity associated clone in the United States [25–27], and
used higher-resolution genome-sequencing data of iso-
lates from the same hospitals as [15, 28] to examine
transmission dynamics and the association between gen-
etic differentiation and patient sharing. We compared
the power of different tools that characterize genetic
differentiation when applied to genome sequencing data
of the MRSA population on the county level. We also
investigated the factors associated with within- and
between-hospital genetic diversity. Our goal was both to
assess whether the results of Ke et al. were replicated
using genomic data, and to compare measures of popu-
lation substructure for their ability to detect migration
of bacteria – in this case assumed to be via patient
transfer from the community and between hospitals –
using different kinds of genetic/genomic data.
Materials and methods
Sample selection
A total of 986 methicillin-resistant Staphylococcus aur-
eus isolates assigned as USA300 collected between 2008
and 2010 from 30 hospitals in Orange County, Califor-
nia, USA were selected from a previously published
study [15, 28]. Hospitals were instructed to provide iso-
lates from unique patients. The sample sizes and the
numbers of hospital- and community-onset isolates are
shown in Additional file 1: Table S1. An isolate was con-
sidered to be hospital-onset if the difference between
admission date and the culture date was greater than
2 days. Community-onset in this study includes both true
community-onset infections and infections in post-
discharge facilities (healthcare-associated community onset
(HA-CO)) because we were not able to distinguish them.
Genome sequencing, SNP calling, and phylogenetic
reconstruction
DNA was extracted using the QIAamp DNA Mini Kit
(Qiagen) and core genomes were sequenced using Illu-
mina HiSeq2000 with 100 bp paired-end reads. Reads
were mapped against the USA300 reference sequence
FPR3757 (accession NC_007793) using SMALT v0.5.8
(http://www.sanger.ac.uk/science/tools/smalt-0) with sub-
sequent realignment around indels using GATKv1.5.9
[29]. The average depth of reads is 115. Single nucleotide
polymorphisms (SNPs) were called using samtools and
subsequently filtered to remove sites with a quality score
less than 50, less than four reads covering the SNP site,
and a SNP/mapping quality ratio less than 0.75. SNPs in
repeat regions identified using RepeatScout [30] and mo-
bile genetic elements were excluded. This resulted in
24,660 SNPs from the core genome. Sequence data were
deposited in the European Nucleotide Archive (project ac-
cession PRJEB2686; for isolate accessions see Additional
file 2: Table S2).
Maximum likelihood as implemented in RAxML
v0.7.4 [31] with the GTRGAMMA model and 100 boot-
strap replications was used to reconstruct a phylogenetic
tree of HA-onset isolates. The tree was plotted using
iTOL v3.0 [32] and branches and tips were colored ac-
cording to the hospital where isolates were collected.
Patient sharing between hospitals
As in Ke et al. [15], patient sharing from hospital A to
hospital B was calculated by
PA−>B ¼ mA−>B=NB
where Ni represents the number of admissions in hospital
i per year and mi->j is the number of patients transferred
from hospital i to hospital j per year. We calculated the
number of patients transferred from hospital i to hospital
j by summing the numbers of direct and indirect patient
transfers. Patient sharing between any two hospitals A and
B was calculated by the taking the average between two
directions:
MAB ¼ PA→B þ PB→A2 :
Genetic differentiation
We used three statistics to characterize genetic differen-
tiation between hospitals: average pairwise difference (π)
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between isolates from different hospitals, FST, and the
proportion of nearly identical isolates (I). FST is based on
the variance of allele frequencies between populations
[33] and was calculated using the R package Hierfstat
[34]. The sample sizes for each hospital range from 1 to
68. Hospitals with sample sizes smaller than 10 were ex-
cluded in the analysis of FST.
The proportion of nearly identical isolates between hospi-
tals (I) is determined by the proportion of isolate pairs with
smaller than 0.15 % differences among all the SNPs
(equivalent to fewer than 37 SNP differences) between hos-
pitals. This threshold is similar to the 40-SNP threshold
used to discount direct transmission in previous studies
[16, 35, 36]. Given that the mutation rate is 1.22 × 10-6 per
site per year for USA300 [37] and the size of core genome
is 2.5 Mb, the divergence per year is about three SNPs.
Thirty-seven SNPs divergence between two genomes there-
fore corresponds to approximately 6.16 (=37/2/3) years on
two lines of descent from the most recent common ances-
tor, indicating that the maximum divergence time for iso-
lates we are counting as ‘nearly identical’ is about 6 years
for the threshold of 37 SNPs and about 4 years for the
lower threshold of 25 SNPs considered in sensitivity ana-
lyses. These divergence times are upper bounds given that
(1) we consider SNP distances up to the threshold as ‘nearly
identical’ and (2) short-term mutation accumulation of bac-
teria occurs faster than long-term evolutionary rates, due to
the survival of weakly deleterious mutations over short but
not long time scales [38].
Within-hospital genetic diversity was calculated by
averaging the proportion of SNP differences between all
pairs of isolates from the same hospital and singleton
SNPs were excluded to minimize the effect of potential
sequencing error and sample size.
Permutation tests
To assess statistical significance of observed correlations,
test statistics were recalculated for 10,000 random per-
mutations of the data, in each of which the hospital
identifier list was permuted relative to the list of isolates.
Coalescent simulation
Coalescent simulation was performed using program ms
[39]. We assume no recombination, constant population
size, an infinite-sites model (all polymorphic sites are
biallelic) and no within-host evolution. We used the
‘steady-state’ number of patients (N*) as population size
in each hospital. N* was calculated by the number of
admissions in each hospital in 1 year times the average
length of stay divided by 365 days. In addition, we as-
sumed that there was a subpopulation with population
size N* = 5000, representing the community, and its
sample size was 0. The sample sizes used in coalescent
simulations were the same as the sample sizes in the
data. We assumed that the mutation rate is eight per
genome per year [40] and that the generation time is
equal to the average of length of stay = 9 days.
We simulated four scenarios: (1) high patient sharing
and high community contribution; (2) high patient shar-
ing and low community contribution; (3) low patient
sharing and high community contribution; and (4) low
patient sharing and low community contribution. For
high patient sharing (1 and 2), empirical patient sharing
from Orange County was used for migration rates be-
tween subpopulations in the coalescent model; for low
patient sharing (3 and 4), migration rate was equal to
empirical patient sharing from Orange County divided
by 100. The number of replicates for each model was
100. The proportion of patients in each hospital that are
from the community (Cfrom), and the proportion of in-
fections in the community that are from each hospital
(Cto) are listed in Table 1.
In addition to infinite-sites model, we also performed
coalescent simulations for a single microsatellite
marker using the infinite-allele model and a stepwise
mutation model [41] in order to compare a single site-
multiple alleles microsatellite marker with multiple
site-biallelic SNPs. The mutation rate of microsatellites
is known to be higher than that of point mutations
[42], and therefore we used 104- and 106-times the
per-site point mutation rate as the mutation rate for
microsatellite model.
Results
Within-hospital and between-hospital genetic diversity
A total of 986 MRSA isolates were sequenced from 30
hospitals in Orange County in 2008 to 2010, across
which 24,660 polymorphic sites were identified in the
core genome.
The average pairwise genetic distance between samples
from the same hospitals was significantly smaller than
that between samples from different hospitals (0.353 %
vs. 0.357 % of all SNP positions, or 87 and 88 SNP dif-
ferences; permutation test (n = 10,000), P value = 0.0045;
Additional file 1: Figure S1A), though the difference be-
tween them was small. SNP differences in this range in-
dicate that the isolates are about 15 years (=87/2/3 and
88/2/3) divergence between each other. Among all the
isolate pairs with no SNP differences, 66 % (31 out of
47) of them were from the same hospital. Among these
31 pairs from the same hospital, 17 pairs of isolates in-
volve hospital-onset isolates (at least one was isolated
after day 2 of the hospital stay), suggesting transmission,
and 10 out of 17 pairs of isolates were collected in the
same month (Additional file 1: Figure S2). Although the
nearest neighbors of some isolates in the phylogeny are
from the same hospital, the phylogeny of all hospital-
onset isolates shows no visual evidence of clustering
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between isolates from the same hospitals (Additional file
1: Figure S3). Together, the distributions of within and
between hospital pairwise distance (Additional file 11
Figure S1A) and the phylogeny (Additional file 1: Figure
S3) suggest that gene flow between hospitals facilitated
by patient sharing between hospitals diluted the genetic
structure to the point that pairwise genetic diversity
cannot be used to distinguish isolates from the same or
different hospitals.
Predictors of within-hospital genetic diversity
We tested the factors that were associated with within-
hospital genetic diversity. Because estimates of the within-
hospital genetic diversity are sensitive to the sample size
(Pearson’s correlation test between within-hospital genetic
diversity and sample size, r = 0.376, P value = 0.045), we
calculated the partial correlation between within-hospital
genetic diversity and other factors when controlling for
the sample size and excluded four hospitals with a sample
size of less than five from analysis.
The number of admissions per year (ranging from
1,068 to 30,930) and the proportion of community-onset
isolates (ranging from 56 % to 100 %) were not signifi-
cantly correlated with within-hospital genetic diversity
(P values = 0.41 and 0.10). The number of hospitals that
a hospital receives patients from (indegree) and the pro-
portion of patients from other hospitals were both posi-
tively correlated with within-hospital genetic diversity
(Pearson partial correlation coefficients = 0.587 and 0.563,
P values = 0.00051 and 0.0011, respectively) (Additional
file 1: Figure S4). The indegree and the proportion of
patients from other hospitals were significantly positively
correlated with each other (Pearson’s correlation r = 0.562,
P value = 0.0028).
Patient sharing as a predictor of genetic differentiation
between pairs of hospitals
We used three methods to characterize genetic differ-
entiation between hospitals: average pairwise difference
(π) between isolates from different hospitals, the fixation
index FST, and the proportion of nearly identical isolates
(I), which is defined as the proportion of isolate pairs with
smaller than 0.15 % differences (equivalent to smaller than
37 SNPs) among all the SNPs between a pair of hospitals.
A similar threshold, 40 SNPs, was used to discount direct
transmission between individual patients in previous stud-
ies [16, 35, 36].
First, we compared genetic differentiation between
hospitals with and without patient sharing. The propor-
tion of nearly identical isolates between hospitals with
patient sharing was significantly larger than that between
hospitals without patient sharing (median = 0.0055 vs. 0;
permutation test (n = 10,000), P value = 0.008, Additional
file 1: Figure S5). FST and the average pairwise difference
π between hospitals with patient sharing were not sig-
nificantly smaller than those without patient sharing
(permutation test (n = 10,000), P values = 0.136 (FST) and
0.900 (π)).
Next we estimated the association between genetic dif-
ferentiation and the level of patient sharing (M). The
proportion of nearly identical isolates between hospitals
was significantly positively correlated with the level of
patient sharing (Pearson’s correlation r between log(I)
and log(M) = 0.185, Mantel test P value = 0.038; Fig. 1).
The results were relatively insensitive to the choice of
SNP difference cutoff values used to define nearly identi-
cal isolates (Additional file 1: Figure S6). The correlation
between FST and the level of patient sharing was weaker
and not statistically significant (Pearson’s correlation r of
log(M) and log(FST) = -0.112, Mantel test P value = 0.11),
and the same applied to the correlation between the
Table 1 Parameter values for coalescent simulations




1 Empirical patient sharing between hospitals 50 % 3 %
2 Empirical patient sharing between hospitals 5 % 1 %
3 One-100th of empirical patient sharing
between hospitals
0.5 % 0.03 %
4 One-100th of empirical patient sharing
between hospitals
0.05 % 0.01 %
aCfrom is the proportion of patients in each hospital that are from the community,
and Cto is the proportion of infections in the community that are from
each hospital
Fig. 1 The proportion of nearly identical isolates increases with the
level of patient sharing (Pearson’s correlation r between log(M) and
log(I) = 0.185, Mantel test P value = 0.038; I and M are the proportion of
nearly identical isolates and the level of patient sharing, respectively)
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average pairwise difference and the level of patient sharing
(Pearson’s correlation r of log(M) and π = 0.085, Mantel
test P value = 0.20).
Examining discrepancies between results with different
measures of genetic differentiation
Isolate pairs with smaller SNP differences were more
likely to come from the same hospitals or hospitals with
a higher level of patient sharing (Fig. 2), suggesting that
patient sharing transmits strains between hospitals. We
hypothesized that the lack of significant association be-
tween patient sharing and FST or π is because these
measures are less powerful than the proportion of
nearly identical isolates for detecting population struc-
ture when gene flow between populations is high, as in
the case here, since the latter is particularly sensitive to
detecting recent transmission events. For example, in
Wright’s island model with the same subpopulation
sizes and migration rates among them [43], FST at equi-
librium is approximately 1/(1 + 2Nm), where N is the
size of each subpopulation and m is the migration rate
between subpopulations [44]. It is therefore expected
that when Nm is large, FST is not very sensitive to each
unit change in Nm. When patient sharing is high, ex-
change of alleles between hospitals is expected to be
frequent, and allele frequencies in different hospitals
tend to be similar. In this case, the impact of genetic
drift and sampling error on allele frequencies can be
similar to that of patient sharing. Because π and FST are
based on allele frequencies, their powers to detect the
effect of patient sharing is lower.
We performed coalescent simulations to test our hy-
pothesis. We simulated four scenarios: (1) high patient
sharing (corresponding to migration between populations
in the coalescent model) and high community contribu-
tion (corresponding to migration from an unsampled
population with large population size); (2) high patient
sharing and low community contribution; (3) low patient
sharing and high community contribution; and (4) low
patient sharing and low community contribution. The
parameter values are described in Methods and shown
in Table 1. The results show that when patient sharing
between hospitals is high, either due to high patient
transfer between hospitals (Model 2) or high level of
community-onset infections in hospitals (Model 3) or
both (Model 1), using the proportion of nearly identi-
cal isolates is more powerful than FST because it is sen-
sitive to recent transmission events if proper SNP
difference cutoff values are used (Fig. 3). If patient
sharing is low (Model 4), the SNP difference between
isolates from different hospitals is high and the propor-
tion of nearly identical isolates is often 0 and less use-
ful when the threshold is small (Fig. 3). The average
pairwise difference is generally less powerful because it
highly depends on allele frequency. For example, if
allele frequencies in two hospitals are both 0.5, it sug-
gests that genetic differentiation is low, but the average
pairwise difference between hospitals in this case
appears to be high (π =0.5). We also showed that the
stochastic variation of FST and π between simulation
runs is higher than that of the proportion of nearly
identical isolates (Additional file 1: Figure S7).
(A) (B)
Fig. 2 Isolate pairs with smaller SNP differences were more likely to come from the same hospital or hospitals with higher level of patient
sharing. a Isolate pairs with smaller SNP differences were more likely to come from the same hospital (red line) than 100 permutations of random
assignment of hospitals (gray lines). b In order to obtain the effect of different levels patient sharing, we calculated normalized proportion of
pairs, which is the quantity (Nki/Ni)/(Nk/N), where N is the total number of pairs of isolates, Nk is the number of pairs of isolates from hospitals
with a particular amount of patient sharing k, Ni is the number of pairs of samples with less than i SNP differences, and Nki is the number of pairs
of samples coming from hospitals with a particular amount of patient sharing k differing by less than i SNPs. Samples collected from the hospitals
with higher level of patient sharing were more likely to have smaller SNP difference. Even a very low level of patient sharing (0.1-0.2 %) shows
higher normalized proportion of pairs with smaller SNP differences than no patient sharing
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FST of microsatellite markers
Because we were extending an analysis to genomic data
that had previously been performed with spa typing, we
sought to understand how allele-frequency based analyses
with single-locus markers compared to genome-wide,
SNP-based analyses. The mutational process of the spa
gene is complex, including deletion, duplication, and point
mutations. For simplicity and generality, we compared the
power of FST derived from a single-locus multiple-alleles
microsatellite marker with that of multiple-locus biallelic
SNPs to detect the effect of patient sharing. We ran com-
puter simulations using two models for the microsatellite
locus: an infinite alleles model and a stepwise mutation
model. In the infinite alleles model, each mutation leads
to a new allele; in stepwise mutation model, each mutation
can either increase or decrease the number of sequence
repeats by 1. We assumed the mutation rate in the micro-
satellite model is 104 or 106-fold higher than the per-site
mutation rate in the multiple-locus SNP model.
When patient sharing is high and the contribution of
strains from community-onset infections is relatively low
(Model 2), FST calculated from microsatellite markers is
more sensitive than FST calculated from multiple-locus
biallelic SNPs (Additional file 1: Figure S8). When the
community contribution is high (Models 1 and 3) the pro-
portion of significant associations using FST calculated
from microsatellite markers and using FST calculated from
multiple-locus biallelic SNPs are similar and both small.
When patient sharing and community contribution are
both low (Model 4), multiple-locus biallelic SNPs perform
better than microsatellite markers. The stochastic vari-
ation in FST of microsatellite markers is smaller than that
of SNPs, and is smaller when mutation rate is higher
(Additional file 1: Figure S7 and S9).
Genetic differentiation and community-onset infections
If the hospitals are closer to each other, they are more
likely to have overlapping community catchment areas.
We hence hypothesized that community-onset infections
in hospitals closer to each other would be similar genetic-
ally. The proportion of nearly identical isolates decreases
with geographic distance (D) (Pearson’s correlation r be-
tween log(I) and D = -0.193, Mantel test P value = 0.086)
and FST increases with geographic distance (Pearson’s cor-
relation r between FST and D = 0.187, Mantel test P value
= 0.076), though only borderline significant, suggesting
that genetic differentiation increases with geographic dis-
tance. However, it is difficult to distinguish the effects of
geographic distance and patient sharing on genetic differ-
entiation, because geographic distance and patient sharing
were highly correlated with each other (Pearson’s correl-
ation r = -0.454, Mantel test P value = 0.0002). Ideally, we
could separate hospital-onset (HO) and community-onset
(CO) samples into two groups and test whether the asso-
ciation between genetic differentiation and geographic
distance is higher in the CO group and the association
Fig. 3 The power of π, FST, and the proportion of nearly identical isolates to detect the effect of patient sharing. The proportion of nearly identical
isolates is more powerful than π and FST if the threshold for nearly identical isolates is chosen properly. FST is more sensitive to changes in patient
sharing if patient sharing is high (Model 4). π is less powerful in all four models here
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between genetic differentiation and patient sharing is
stronger in the HO group, but our sample sizes are not
sufficient for performing these tests.
Moreover, we tested the effect of average CO propor-
tions on genetic differentiation between hospitals. The
correlation between the average CO proportion and FST
(Pearson’s correlation r = -0.143, Mantel test P value =
0.20) and the correlation between the average CO propor-
tion and the log of the proportion of nearly identical iso-
lates (Pearson’s correlation r = 0.156, Mantel test P value
= 0.21) were not significant. Because the effect of average
CO proportions on genetic differentiation may depend on
the level of overlapping communities, we calculated the
partial correlation between average CO proportions and
genetic differentiation given geographic distance between
hospitals. The partial correlation of average CO propor-
tion and genetic differentiation were still not significant
after controlling for geographic distances between hospi-
tals (log(I), Pearson’s correlation r = 0.174, Mantel test P
value = 0.19; FST, Pearson’s correlation r = -0.160, Mantel
test P value = 0.16). The lack of statistically significant im-
pact of CO proportion here could be due to the limited
variation in CO proportion across hospitals (Additional
file 1: Table S1).
Discussion
In this study, we used genome sequencing data of 986
MRSA regional isolates to study MRSA transmission
within and between hospitals and between hospitals and
their surrounding community. We confirmed the impact
of patient sharing on population structure [15] by show-
ing a positive correlation between the proportion of
nearly identical isolates between hospitals and the level
of patient sharing. We found that many sample pairs
without any SNP difference were from unique patients
from the same hospital and their time of sample collection
was very close, supporting the presence of within-hospital
transmission, consistent with earlier findings that patient-
to-patient transmission occurs, even if attentive infection
prevention strategies are used [36].
Identifying the effect of patient sharing
Although we detected a significant association between
the proportion of nearly identical isolates and patient
sharing, the association between FST and patient sharing
was not significant. We propose that these different re-
sults might be due to a lack of power of FST when pa-
tient sharing and the contribution of community-onset
infections are high, and we confirmed our hypothesis
by performing coalescent simulations using parameters
informed by empirical data. The association between
patient sharing and FST calculated from spa types in Ke
et al. [15] was likely attributed to the rare and more di-
vergent isolates with spa types that were excluded from
the present study. Although the variation in spa types
is usually too low for detailed tracking of spatial spread
in short-term local settings, if there is enough variation,
it can potentially be powerful because when the rare or
more divergent isolates were shared between hospitals,
it was very likely due to patient sharing.
Only a certain amount of divergence can occur before
a spa change causes the sample to be discarded from the
t008-lineage dataset. If within-hospital diversity reaches
the maximum expected saturation point for within-spa
type diversity, FST is not a suitable measure for genetic dif-
ferentiation between hospitals. Engelthaler et al. showed
that within-spa type diversity can be in the order of thou-
sands of SNPs [45], which is much greater than the
maximum SNP difference (269 bp) in our dataset. This
suggests that it is unlikely that the saturation of within-
t008 diversity lowered the power of FST in our study.
It has been suggested that the cloud of diversity is a
major issue in identifying person-to-person transmission
links [46, 47]. We sequenced a single isolate from each
patient and do not have the information of within-host
genetic diversity. However, we are concerned about
hospital-level rather than patient-level dynamics in this
study, and because the importance of patient-to-patient
transmission effects diminishes considerably at the group
level [47], there is less concern about within-host diversity
here. To directly explore the impact of within-host diver-
sity, multiple within-host pathogen genomic sequences
from a range of scenarios, together with comprehensive
epidemiological data, would be required.
Low level of recombination
S. aureus has been shown to be primarily clonal with
relatively low levels of recombination [37, 48–50]. We
used Gubbins [51] to detect recombination in our data-
set, and identified six regions of recombination, which in
average account for 0.00064 % of genome and 5.93 % of
SNPs. We excluded these regions and repeated our
within-hospital analysis of within-hospital genetic diver-
sity and the association between the proportion of nearly
identical isolates, FST and π with patient sharing, and the
results are consistent with the results before removing
recombination (Additional file 1: Table S3). Genealogy-
based methods generally perform better than FST if there
is no recombination [52], however, genealogy-based
parametric methods, such as BEAST [53] or MIGRATE-
N [54, 55], cannot be used for estimating migration rate
between hospitals because the number of parameters is
too high (870 if using non-symmetric migration rates
and 435 if using symmetric migration rates). Moreover,
many pairs of sister strains on the tips of the phylogeny
comes from different hospitals (Additional file 1:
Figure S3), suggesting that many branches would have
multiple migration events. Therefore, even if parametric
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methods were used to reduce the number of separate
migration rates to estimate, the inference of rates is less
reliable and many combinations of estimates might fit the
data equally well.
Star-like phylogeny
The phylogenetic tree we constructed shows relatively
long external branches compared with internal branches
(Additional file 1: Figure S3). A similar shape of phylogeny
has also been seen in other studies of S. aureus in the
United States [37, 56]. There are five possible explanations
for star-like phylogeny: recombination [57, 58]; sequen-
cing error; population expansion [59]; selective sweep
[60]; and long-term colonization. The phylogeny after re-
moving recombination regions detected by Gubbins is still
star-like (Additional file 1: Figure S10), suggesting that re-
combination is unlikely to be the reason. We could not
entirely rule out the possibility of sequencing error, but
because we were still able to find several pairs of identical
isolates, we think it does not play a major role in our data-
set. Given that USA300 is a recently emerging clone [25],
it is possible that population expansion and/or a selective
sweep leads to the longer external branches. To test this
hypothesis and to explore possible mechanisms resulting
in such dynamics, further research would be required. Fi-
nally, long-term persistence in the host can lead to long
external branches in the phylogeny [61], and because
MRSA colonization sometimes persist for a long time
[62], intra-host evolution can potentially explain part of
the pattern seen here.
Comparing genome-wide SNP with a single microsatellite
marker
Our simulation results also indicate that, when FST is used,
genomic SNP data are not always more powerful than
microsatellite markers (though the proportion of nearly
identical isolates identified by genome-wide SNP data is
more powerful than microsatellite FST in our four models).
When there is no recombination, there is one single evo-
lutionary tree for all loci, and FST calculated from genome-
wide SNP does not benefit from taking the average of
multiple partially independent trees as it would in organ-
isms with frequent recombination. Microsatellite markers
are more sensitive to recent events than to events in the
distant past because each new mutation can potentially
lead to a new allele and the number of mutations (or the
divergence time) between alleles is not trackable. Also, in
the long term, a series of mutations can lead to conver-
gence that would be misinterpreted as identity by descent
[24, 63]. When patient sharing is high and community
contribution is relatively low, microsatellite markers
perform better than SNPs. In contrast, when patient
sharing is low, the power of microsatellite markers is
lower. Regions such as microsatellites that mutate rapidly
are difficult to assay using next-generation sequencing
methods based on short reads, but technological advances
have the potential to greatly increase the read length [64],
and we can expect that this will make these regions and
their variation accessible to genomic analyses.
Conclusions
With advances in sequencing technologies, very large
samples of pathogen genomes are becoming available and
can be used for studying disease transmission. Pathogen
samples can be collected across different geographic
scales, such as on the country, city, or hospital levels. Here
we showed that for samples from different hospitals in the
same county, the proportion of nearly identical isolates
was more useful for detecting the effect of patient sharing
than the classical statistic FST when using genomic data,
and that FST calculated from genome sequencing data is
not always more powerful than FST calculated from micro-
satellite markers.
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